Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761858
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on Social Appearance Anxiety in Patients Undergoing Cosmetic SurgeryAydin Adnan Menderes UniversityActive Not Recruiting
NCT07761858Active Not Recruiting
—
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on...Aydin Adnan Menderes Univ...
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
NCT07759778
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu YiNot Yet RecruitingPhase 4
NCT07759778Not Yet Recruiting
Phase 4
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu Yi
NCT07759349
Comparison Of Acetaminophen, NSAIDs, And Trypsin-Chymotrypsin Plus Acetaminophen For Post-Endodontic Pain After Single-Visit Root Canal TreatmentDow University of Health SciencesRecruitingEarly Phase 1
NCT07759349Recruiting
Early Phase 1
Comparison Of Acetaminophen, NSAIDs, And Trypsin-Chymotrypsin Plus Acetaminophen...Dow University of Health...
NCT07761832
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRENT-ICU Study)Hospital H+ QueretaroCompleted
NCT07761832Completed
—
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRE...Hospital H+ Queretaro
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary SyndromeMst.Sumyara KhatunCompletedNot Applicable
NCT07759518Completed
Not Applicable
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian St...Mst.Sumyara Khatun
NCT07760831
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisJiangsu HengRui Medicine Co., Ltd.Not Yet RecruitingPhase 1
NCT07760831Not Yet Recruiting
Phase 1
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerativ...Jiangsu HengRui Medicine...
NCT07761208
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye UniversityNot Yet Recruiting
NCT07761208Not Yet Recruiting
—
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye University
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759583
Effects of Buteyko Breathing Versus Incentive Spirometry on Oxygen Saturation, Dyspnoea, Exercise Tolerance, and Sputum Clearance in Patients With Smog Induced PneumoniaLahore University of Biological and Applied SciencesRecruitingNot Applicable
NCT07759583Recruiting
Not Applicable
Effects of Buteyko Breathing Versus Incentive Spirometry on Oxygen Saturation, D...Lahore University of Biol...
NCT07760077
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceutical Research and Development Center LTDNot Yet RecruitingPhase 1
NCT07760077Not Yet Recruiting
Phase 1
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceuti...
NCT07761143
Impact of Device Free Summer Camp on Adolescent Mental Health and WellbeingRady Children's Hospital, San DiegoCompletedNot Applicable
NCT07761143Completed
Not Applicable
Impact of Device Free Summer Camp on Adolescent Mental Health and WellbeingRady Children's Hospital,...
NCT07760792
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial ColonizationAl-Azhar UniversityNot Yet Recruiting
NCT07760792Not Yet Recruiting
—
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial Colo...Al-Azhar University
NCT07760350
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Minority Health and Health Disparities (NIMHD)Not Yet RecruitingNot Applicable
NCT07760350Not Yet Recruiting
Not Applicable
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Min...
NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07761923Not Yet Recruiting
Not Applicable
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska Institutet
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 41 (5%)
Early Phase 11 (5%)
Phase 21 (5%)